Exagen Inc.
XGN
$7.31
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.92% | 11.67% | 21.79% | 37.87% | 14.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.92% | 11.67% | 21.79% | 37.87% | 14.19% |
| Cost of Revenue | 13.47% | 11.39% | 43.40% | 29.73% | 13.30% |
| Gross Profit | 17.53% | 11.86% | 8.60% | 44.32% | 14.79% |
| SG&A Expenses | 8.41% | 7.69% | 21.76% | 12.61% | 10.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.23% | 9.84% | 26.81% | 18.49% | 12.36% |
| Operating Income | 34.52% | -1.46% | -47.06% | 33.52% | -1.66% |
| Income Before Tax | 27.40% | -4.77% | -24.30% | -40.93% | -48.42% |
| Income Tax Expenses | -- | -- | 8.33% | -- | -- |
| Earnings from Continuing Operations | 28.00% | -5.73% | -24.25% | -40.95% | -49.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.00% | -5.73% | -24.25% | -40.95% | -49.66% |
| EBIT | 34.52% | -1.46% | -47.06% | 33.52% | -1.66% |
| EBITDA | 49.45% | 3.76% | -47.41% | 41.33% | -0.28% |
| EPS Basic | 37.15% | 17.75% | 2.89% | -12.16% | -28.98% |
| Normalized Basic EPS | 34.19% | 0.24% | -30.50% | 30.10% | -6.67% |
| EPS Diluted | 37.15% | 17.75% | 2.89% | -12.16% | -28.98% |
| Normalized Diluted EPS | 34.19% | 0.24% | -30.50% | 30.10% | -6.67% |
| Average Basic Shares Outstanding | 14.60% | 28.55% | 27.93% | 25.67% | 15.99% |
| Average Diluted Shares Outstanding | 14.60% | 28.55% | 27.93% | 25.67% | 15.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |